THE BRITISH SOCIETY FOR CLINICAL NEUROPHYSIOLOGY
To promote and assist the science and practice of clinical neurophysiology.
Latest income
£82k
Latest spending
£36k
Registered
1982
Accounts read
FY2025
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net surplus of £45,383 for the year ended 30 June 2025, with total income of £79,790. Per the trustees' report, the society holds £229,586 in unrestricted funds, which they consider sufficient to mitigate risks and fund future activities.
What the accounts disclose
Reserves policy: sufficient to underwrite any potential losses in respect of the next triennial teaching course (held: £230k)
“The Society holds reserves sufficient to underwrite any potential losses in respect of the next triennial teaching course.” — page 6
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Adrian Prize awarded to trustee Dr Charles Fry
“There were no disclosable related party transactions during the year (2024 - none), aside from the award of the £1,000 Adrian Prize to trustee Dr Charles Fry.” — page 22
Per its FY2025 accounts as filed with the Charity Commission.
Trustees
- Dr Ronit Presslerchair
- Dr Andrew Michell
- Dr Brython Hywel
- Dr GARETH PAYNE FRCP FRCPE
- Dr Julia Attard Navarro
- Dr Samantha Jefferson
- Dr Sushma Goyal
- Dr Syed Shah
- Dr Tatyana Yermakova
- Dr Veronica Leach
- Dr Zaloa Agirre-Arrizubieta
- Professor Mark Baker FRCP
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £82k | £36k |
| 30/06/2024 | £71k | £68k |
| 30/06/2023 | £61k | £47k |
| 30/06/2022 | £49k | £21k |
| 30/06/2021 | £29k | £26k |
Common questions
Is THE BRITISH SOCIETY FOR CLINICAL NEUROPHYSIOLOGY financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net surplus of £45,383 for the year ended 30 June 2025, with total income of £79,790. Per the trustees' report, the society holds £229,586 in unrestricted funds, which they consider sufficient to mitigate risks and fund future activities. Its FY2025 accounts were independently examined.